Extended Stability for Parenteral Drugs

Get the support you need to safely extend dating of parenteral drugs beyond the usual 24-hour limit - minimizing waste, lowering medication costs, and enabling optimal patient administration schedules at alternate infusion sites.

---

Get the support you need to safely extend dating of parenteral drugs beyond the usual 24-hour limit—minimizing waste, lowering medication costs, and enabling optimal patient administration schedules at alternate infusion sites. The new seventh edition features the inclusion of monographs expanded beyond home infusion to be inclusive of all clinical settings where parenteral drugs are stored or compounded.

ASHP’s seventh edition of Extended Stability for Parenteral Drugs, by Michelle C. Simpson, PharmD, BCSCP and Eric G. Schaefer, PharmD, MHSA, covers all aspects of determining stability, including the changing elastomeric landscape and the ongoing variability in stability data.

New in this edition:
All 196 stability monographs completely updated.
Including 37 new monographs.
Newly published stability information for parenteral nutrition, oncology, specialty, and COVID medications.
An extensive list of medications with temperature excursion data for intact vials.
Each monograph contains updated extended drug stability data specific to: container, drug manufacturer, concentration, and diluent.
Stability timeframes include standardized temperatures for room, refrigerated, frozen, post thaw, and body temperatures.
Inclusion of monographs expanded beyond home infusion to be inclusive of all clinical settings where parenteral drugs are stored or compounded.